Skip to content

Superficial Cervical Plexus Block for Shoulder Pain After Lung Surgery

The Effect of Superficial Cervical Plexus Block on Post-Thoracotomy/Scopy Ipsilateral Shoulder Pain

Status
Terminated
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01550302
Acronym
SCPB
Enrollment
10
Registered
2012-03-09
Start date
2013-10-31
Completion date
2014-05-31
Last updated
2017-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder Pain

Keywords

Superficial Cervical Plexus Block, Thoracic Surgery, Thoracotomy, Video-Assisted Thoracoscopic Surgery

Brief summary

The investigators want to know whether injecting numbing medication on the side of the neck (also called superficial cervical plexus block) can prevent or reduce shoulder pain that patients commonly experience after lung surgery. The investigators will perform the injection at the end of your surgery while the subjects are still under general anesthesia and before they wake up. The investigators will use a local anesthetic (bupivacaine or Marcaine®) that is routinely used for skin infiltration of the surgical wounds. This study is randomized and single-blind. This means that subjects will be assigned by chance (like flipping a coin) to receive either an injection with active medication (bupivacaine), or no injection at all.

Detailed description

Pain management following lung surgery is of outmost importance. Providing adequate pain control facilitates patient recovery and improves lung function, therefore, leading to reduced morbidity and mortality associated with lung surgery. It is now well-established that lung surgery is associated with significant incisional pain, which in some patients may lead to development of chronic post-thoracotomy pain syndrome. In addition, many patients report significant shoulder pain that is often resistant to increasing epidural infusions and intravenous opioid therapy. The incidence of shoulder pain varies from study to study with estimates anywhere between 41% to 97%. Although the cause of the shoulder pain is not well understood, there are only few therapies available for the treatment of shoulder pain including acetaminophen, non-steroidal anti-inflammatory drugs, interscalene brachial plexus and stellate ganglion block. However, all of the currently available therapies have potentially significant side-effects. The investigators are not aware of any studies evaluating the effectiveness of superficial cervical plexus block in reducing or preventing shoulder pain following thoracotomy or thoracoscopic surgery. The superficial cervical plexus block is minimal risk procedure equivalent to an IV start. The primary aim of this study is to compare the effect of superficial cervical plexus block when added to thoracic epidural analgesia and intravenous patient controlled analgesia (PCA) to standard thoracic epidural analgesia and PCA used at our institution on the incidence of shoulder pain. Subjects participating in this study will receive standard clinical care in addition to the following research procedures: * Intra-operative block: an injection of bupivacaine on the side of the neck at the end of the surgery while the subject is still under general anesthesia or no injection at all if in control group. If the subject is assigned to receive an injection, the investigators will be using a small needle similar to the one used to numb the skin for the IV start. There will be a single needle stick on the side of the neck (same side as the lung surgery) and injection of 15 mL of 0.25% bupivacaine under the skin. Regardless of whether the subject gets an injection or not, he/she will receive standard clinical care. * Post-lung surgery pain assessment: the investigators will ask the subjects to rate their pain at the incision site, chest tube site and shoulder at rest and with movement at 6, 12, 18, 24 and 48 hours after lung surgery. The investigators will also ask the subjects about any side-effects that may be associated with the standard narcotic pain medications. The investigators will collect the following data from the medical record including: * Presence or absence of shoulder pain * The amount of pain medicines (narcotics) needed to treat subject's pain over 24 and 48 hours after lung surgery * The presence of any side-effects of narcotic pain medications * Blood pressure, heart rate, EKG and oxygen levels when available in order to evaluate if improved shoulder pain and less narcotics used will have additional beneficial effects Subjects are eligible if they are age 18-75 years and undergoing lung surgery. Subjects are not eligible if they are non-English speaking, have had a previous lung surgery, are allergic to bupivacaine, have a history of chronic pain or have been taking pain medications for a long time, and already have shoulder pain.

Interventions

At the end of the lung surgery while subjects are still under general anesthesia, one of the investigators will perform superficial cervical plexus. First, a line extending from the mastoid process to C6 transverse process is drawn. The site of needle insertion is marked at the midpoint of the line connecting the mastoid process with Chassaignac's tubercle of C6 transverse process. After skin cleansing with chlorhexidine prep, using a fan technique with superior-inferior needle redirections, 15 ml of 0.25% bupivacaine will be injected alongside the posterior border of the sternocleidomastoid muscle 2-3 cm below and above the needle insertion site.

DRUGBupivacaine

Single dose of 37.5 mg of bupivacaine subcutaneously

Sponsors

University of Washington
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* subjects who clinically consented to elective thoracotomy or video-assisted thoracoscopic surgery (VATS) under general anesthesia and epidural analgesia * ages between 18 and 75 years

Exclusion criteria

* inability to perform thoracic epidural * violation of protocol (e.g., administration of medication that does not comply with the study protocol) * subject has change of mind * surgery has to be repeated Non-inclusion Criteria: * subject refusal * non-English speaking * previous chronic or neuropathic pain * previous chronic use of opioids * history of psychiatric disorder * allergy to local anesthetic * previous ipsilateral thoracotomy or VATS * prior history of shoulder pain

Design outcomes

Primary

MeasureTime frame
Incidence of Post-thoracotomy/Scopy Ipsilateral Shoulder Pain24 hours after lung surgery

Secondary

MeasureTime frameDescription
Numeric Response Scale Pain Scores Around Ipsilateral Shoulder at Rest and During Movement6, 12, 18, 24 and 48 hours after the surgeryData collected on an interval scale ranging from 0 (no pain) to 10 (highest or most pain). Reported data shows an average of scores across participants
Numeric Response Scale Pain Scores at Incision Site at Rest and During Coughing6, 12, 18, 24 and 48 hours after the surgeryData collected on an interval scale ranging from 0 (no pain) to 10 (highest or most pain). Reported data shows an average of scores across participants
Post-operative Opioid Consumption Expressed in Morphine Equivalents24 hours after the surgery
Number of Participants Requiring Post-operative Ibuprofen as a Rescue Medication48 hours after the surgery
Number of Patients With Post-operative Side Effects Such as Post-operative Nausea and Vomiting (PONV), Pruritus, Sedation, Respiratory Depression and Hypotension24 and 48 hours after the surgery
Numeric Response Scale Pain Scores Around Chest Tube Insertion Site at Rest and During Coughing6, 12, 18, 24 and 48 hours after the surgeryData collected on an interval scale ranging from 0 (no pain) to 10 (highest or most pain). Reported data shows an average of scores across participants

Countries

United States

Participant flow

Participants by arm

ArmCount
Controls
Subjects enrolled in this group will only have a line drawn on the side of their neck for superficial cervical plexus block, but we will not perform the injection. The subjects will not be aware whether they received an intra-operative block or not. In addition, neither the Post-Anesthesia Care Unit nurse nor the providers involved in the post-operative care will be aware of subjects group assignment.
5
Superficial Cervical Plexus Block
Subjects enrolled in this group will have a line drawn and will receive a superficial cervical plexus block at the end of the surgery just prior to emergence from anesthesia. Superficial Cervical Plexus Block: At the end of the lung surgery while subjects are still under general anesthesia, one of the investigators will perform superficial cervical plexus. First, a line extending from the mastoid process to C6 transverse process is drawn. The site of needle insertion is marked at the midpoint of the line connecting the mastoid process with Chassaignac's tubercle of C6 transverse process. After skin cleansing with chlorhexidine prep, using a fan technique with superior-inferior needle redirections, 15 ml of 0.25% bupivacaine will be injected alongside the posterior border of the sternocleidomastoid muscle 2-3 cm below and above the needle insertion site. Bupivacaine: Single dose of 37.5 mg of bupivacaine subcutaneously
5
Total10

Baseline characteristics

CharacteristicControlsSuperficial Cervical Plexus BlockTotal
Age, Continuous58.8 years
STANDARD_DEVIATION 8.7
58.8 years
STANDARD_DEVIATION 6.7
58.8 years
STANDARD_DEVIATION 7.3
Duration of Surgery181 minutes
STANDARD_DEVIATION 70
251 minutes
STANDARD_DEVIATION 108
216 minutes
STANDARD_DEVIATION 96
Height181.0 cm
STANDARD_DEVIATION 7.6
156.4 cm
STANDARD_DEVIATION 4.6
168.7 cm
STANDARD_DEVIATION 13.8
Region of Enrollment
United States
5 participants5 participants10 participants
Sex: Female, Male
Female
1 Participants5 Participants6 Participants
Sex: Female, Male
Male
4 Participants0 Participants4 Participants
Weight89.7 kg
STANDARD_DEVIATION 6
66.2 kg
STANDARD_DEVIATION 18.7
77.9 kg
STANDARD_DEVIATION 18.2

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 50 / 5
serious
Total, serious adverse events
0 / 50 / 5

Outcome results

Primary

Incidence of Post-thoracotomy/Scopy Ipsilateral Shoulder Pain

Time frame: 24 hours after lung surgery

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
ControlsIncidence of Post-thoracotomy/Scopy Ipsilateral Shoulder Pain2 Participants
Superficial Cervical Plexus BlockIncidence of Post-thoracotomy/Scopy Ipsilateral Shoulder Pain3 Participants
Secondary

Number of Participants Requiring Post-operative Ibuprofen as a Rescue Medication

Time frame: 48 hours after the surgery

ArmMeasureValue (NUMBER)
ControlsNumber of Participants Requiring Post-operative Ibuprofen as a Rescue Medication0 number of participants
Superficial Cervical Plexus BlockNumber of Participants Requiring Post-operative Ibuprofen as a Rescue Medication1 number of participants
Secondary

Number of Patients With Post-operative Side Effects Such as Post-operative Nausea and Vomiting (PONV), Pruritus, Sedation, Respiratory Depression and Hypotension

Time frame: 24 and 48 hours after the surgery

Population: Hypotension data not collected

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
ControlsNumber of Patients With Post-operative Side Effects Such as Post-operative Nausea and Vomiting (PONV), Pruritus, Sedation, Respiratory Depression and HypotensionPONV 24 hrs2 Participants
ControlsNumber of Patients With Post-operative Side Effects Such as Post-operative Nausea and Vomiting (PONV), Pruritus, Sedation, Respiratory Depression and HypotensionPONV 48 hrs2 Participants
ControlsNumber of Patients With Post-operative Side Effects Such as Post-operative Nausea and Vomiting (PONV), Pruritus, Sedation, Respiratory Depression and HypotensionPruritis 24 hrs1 Participants
ControlsNumber of Patients With Post-operative Side Effects Such as Post-operative Nausea and Vomiting (PONV), Pruritus, Sedation, Respiratory Depression and HypotensionPruritis 48 hrs2 Participants
ControlsNumber of Patients With Post-operative Side Effects Such as Post-operative Nausea and Vomiting (PONV), Pruritus, Sedation, Respiratory Depression and HypotensionDizziness 24 hrs0 Participants
ControlsNumber of Patients With Post-operative Side Effects Such as Post-operative Nausea and Vomiting (PONV), Pruritus, Sedation, Respiratory Depression and HypotensionDizziness 48 hrs0 Participants
ControlsNumber of Patients With Post-operative Side Effects Such as Post-operative Nausea and Vomiting (PONV), Pruritus, Sedation, Respiratory Depression and HypotensionSedation 24 hrs1 Participants
ControlsNumber of Patients With Post-operative Side Effects Such as Post-operative Nausea and Vomiting (PONV), Pruritus, Sedation, Respiratory Depression and HypotensionSedation 48 hrs0 Participants
ControlsNumber of Patients With Post-operative Side Effects Such as Post-operative Nausea and Vomiting (PONV), Pruritus, Sedation, Respiratory Depression and HypotensionRespiratory Depression 24 hrs1 Participants
ControlsNumber of Patients With Post-operative Side Effects Such as Post-operative Nausea and Vomiting (PONV), Pruritus, Sedation, Respiratory Depression and HypotensionRespiratory Depression 48 hrs1 Participants
Superficial Cervical Plexus BlockNumber of Patients With Post-operative Side Effects Such as Post-operative Nausea and Vomiting (PONV), Pruritus, Sedation, Respiratory Depression and HypotensionSedation 48 hrs0 Participants
Superficial Cervical Plexus BlockNumber of Patients With Post-operative Side Effects Such as Post-operative Nausea and Vomiting (PONV), Pruritus, Sedation, Respiratory Depression and HypotensionPONV 24 hrs1 Participants
Superficial Cervical Plexus BlockNumber of Patients With Post-operative Side Effects Such as Post-operative Nausea and Vomiting (PONV), Pruritus, Sedation, Respiratory Depression and HypotensionDizziness 48 hrs1 Participants
Superficial Cervical Plexus BlockNumber of Patients With Post-operative Side Effects Such as Post-operative Nausea and Vomiting (PONV), Pruritus, Sedation, Respiratory Depression and HypotensionPONV 48 hrs4 Participants
Superficial Cervical Plexus BlockNumber of Patients With Post-operative Side Effects Such as Post-operative Nausea and Vomiting (PONV), Pruritus, Sedation, Respiratory Depression and HypotensionRespiratory Depression 48 hrs0 Participants
Superficial Cervical Plexus BlockNumber of Patients With Post-operative Side Effects Such as Post-operative Nausea and Vomiting (PONV), Pruritus, Sedation, Respiratory Depression and HypotensionPruritis 24 hrs1 Participants
Superficial Cervical Plexus BlockNumber of Patients With Post-operative Side Effects Such as Post-operative Nausea and Vomiting (PONV), Pruritus, Sedation, Respiratory Depression and HypotensionSedation 24 hrs0 Participants
Superficial Cervical Plexus BlockNumber of Patients With Post-operative Side Effects Such as Post-operative Nausea and Vomiting (PONV), Pruritus, Sedation, Respiratory Depression and HypotensionPruritis 48 hrs0 Participants
Superficial Cervical Plexus BlockNumber of Patients With Post-operative Side Effects Such as Post-operative Nausea and Vomiting (PONV), Pruritus, Sedation, Respiratory Depression and HypotensionRespiratory Depression 24 hrs0 Participants
Superficial Cervical Plexus BlockNumber of Patients With Post-operative Side Effects Such as Post-operative Nausea and Vomiting (PONV), Pruritus, Sedation, Respiratory Depression and HypotensionDizziness 24 hrs0 Participants
Secondary

Numeric Response Scale Pain Scores Around Chest Tube Insertion Site at Rest and During Coughing

Data collected on an interval scale ranging from 0 (no pain) to 10 (highest or most pain). Reported data shows an average of scores across participants

Time frame: 6, 12, 18, 24 and 48 hours after the surgery

Population: Data not collected for 6, 12, and 18 hours at rest or with movement/cough

ArmMeasureGroupValue (MEAN)Dispersion
ControlsNumeric Response Scale Pain Scores Around Chest Tube Insertion Site at Rest and During CoughingAt rest 48 hrs1.6 units on a scaleStandard Deviation 2.61
ControlsNumeric Response Scale Pain Scores Around Chest Tube Insertion Site at Rest and During CoughingMovement or cough 24 hrs3.6 units on a scaleStandard Deviation 3.58
ControlsNumeric Response Scale Pain Scores Around Chest Tube Insertion Site at Rest and During CoughingMovement or cough 48 hrs4.2 units on a scaleStandard Deviation 3.11
ControlsNumeric Response Scale Pain Scores Around Chest Tube Insertion Site at Rest and During CoughingAt rest 24 hrs2.6 units on a scaleStandard Deviation 2.88
Superficial Cervical Plexus BlockNumeric Response Scale Pain Scores Around Chest Tube Insertion Site at Rest and During CoughingMovement or cough 48 hrs5.2 units on a scaleStandard Deviation 3.7
Superficial Cervical Plexus BlockNumeric Response Scale Pain Scores Around Chest Tube Insertion Site at Rest and During CoughingAt rest 24 hrs5.8 units on a scaleStandard Deviation 4.44
Superficial Cervical Plexus BlockNumeric Response Scale Pain Scores Around Chest Tube Insertion Site at Rest and During CoughingMovement or cough 24 hrs7.2 units on a scaleStandard Deviation 3.56
Superficial Cervical Plexus BlockNumeric Response Scale Pain Scores Around Chest Tube Insertion Site at Rest and During CoughingAt rest 48 hrs2.2 units on a scaleStandard Deviation 2.59
UnknownNumeric Response Scale Pain Scores Around Chest Tube Insertion Site at Rest and During CoughingAt rest 6 hrs units on a scale
UnknownNumeric Response Scale Pain Scores Around Chest Tube Insertion Site at Rest and During CoughingMovement or cough 6 hrs units on a scale
UnknownNumeric Response Scale Pain Scores Around Chest Tube Insertion Site at Rest and During CoughingAt rest 12 hrs units on a scale
UnknownNumeric Response Scale Pain Scores Around Chest Tube Insertion Site at Rest and During CoughingMovement or cough 12 hrs units on a scale
UnknownNumeric Response Scale Pain Scores Around Chest Tube Insertion Site at Rest and During CoughingAt rest 18 hrs units on a scale
UnknownNumeric Response Scale Pain Scores Around Chest Tube Insertion Site at Rest and During CoughingMovement or cough 18 hrs units on a scale
Secondary

Numeric Response Scale Pain Scores Around Ipsilateral Shoulder at Rest and During Movement

Data collected on an interval scale ranging from 0 (no pain) to 10 (highest or most pain). Reported data shows an average of scores across participants

Time frame: 6, 12, 18, 24 and 48 hours after the surgery

Population: Data not collected for 6, 12, and 18 hours at rest or with movement/coughing

ArmMeasureGroupValue (MEAN)Dispersion
ControlsNumeric Response Scale Pain Scores Around Ipsilateral Shoulder at Rest and During MovementAt rest 48 hrs2.2 units on a scaleStandard Deviation 3.03
ControlsNumeric Response Scale Pain Scores Around Ipsilateral Shoulder at Rest and During MovementWith movement 24 hrs2.8 units on a scaleStandard Deviation 4.21
ControlsNumeric Response Scale Pain Scores Around Ipsilateral Shoulder at Rest and During MovementWith movement 48 hrs3.4 units on a scaleStandard Deviation 3.13
ControlsNumeric Response Scale Pain Scores Around Ipsilateral Shoulder at Rest and During MovementAt rest 24 hrs2.8 units on a scaleStandard Deviation 4.21
Superficial Cervical Plexus BlockNumeric Response Scale Pain Scores Around Ipsilateral Shoulder at Rest and During MovementWith movement 48 hrs5.8 units on a scaleStandard Deviation 4.38
Superficial Cervical Plexus BlockNumeric Response Scale Pain Scores Around Ipsilateral Shoulder at Rest and During MovementAt rest 24 hrs4 units on a scaleStandard Deviation 3
Superficial Cervical Plexus BlockNumeric Response Scale Pain Scores Around Ipsilateral Shoulder at Rest and During MovementWith movement 24 hrs5.6 units on a scaleStandard Deviation 3.13
Superficial Cervical Plexus BlockNumeric Response Scale Pain Scores Around Ipsilateral Shoulder at Rest and During MovementAt rest 48 hrs4.6 units on a scaleStandard Deviation 4.62
UnknownNumeric Response Scale Pain Scores Around Ipsilateral Shoulder at Rest and During MovementAt rest 6 hrs units on a scale
UnknownNumeric Response Scale Pain Scores Around Ipsilateral Shoulder at Rest and During MovementMovement or cough 6 hrs units on a scale
UnknownNumeric Response Scale Pain Scores Around Ipsilateral Shoulder at Rest and During MovementAt rest 12 hrs units on a scale
UnknownNumeric Response Scale Pain Scores Around Ipsilateral Shoulder at Rest and During MovementMovement or cough 12 hrs units on a scale
UnknownNumeric Response Scale Pain Scores Around Ipsilateral Shoulder at Rest and During MovementAt rest 18 hrs units on a scale
UnknownNumeric Response Scale Pain Scores Around Ipsilateral Shoulder at Rest and During MovementMovement or cough 18 hrs units on a scale
Secondary

Numeric Response Scale Pain Scores at Incision Site at Rest and During Coughing

Data collected on an interval scale ranging from 0 (no pain) to 10 (highest or most pain). Reported data shows an average of scores across participants

Time frame: 6, 12, 18, 24 and 48 hours after the surgery

Population: Data not collected for 6, 12, and 18 hours at rest or moving/with cough

ArmMeasureGroupValue (MEAN)Dispersion
ControlsNumeric Response Scale Pain Scores at Incision Site at Rest and During CoughingAt rest 48 hrs1.6 units on a scaleStandard Deviation 2.19
ControlsNumeric Response Scale Pain Scores at Incision Site at Rest and During CoughingMovement or cough 24 hrs5.2 units on a scaleStandard Deviation 4.15
ControlsNumeric Response Scale Pain Scores at Incision Site at Rest and During CoughingMovement or cough 48 hrs3.8 units on a scaleStandard Deviation 3.03
ControlsNumeric Response Scale Pain Scores at Incision Site at Rest and During CoughingAt rest 24 hrs4.4 units on a scaleStandard Deviation 4.04
Superficial Cervical Plexus BlockNumeric Response Scale Pain Scores at Incision Site at Rest and During CoughingMovement or cough 48 hrs5.2 units on a scaleStandard Deviation 4.15
Superficial Cervical Plexus BlockNumeric Response Scale Pain Scores at Incision Site at Rest and During CoughingAt rest 24 hrs3.2 units on a scaleStandard Deviation 4.38
Superficial Cervical Plexus BlockNumeric Response Scale Pain Scores at Incision Site at Rest and During CoughingMovement or cough 24 hrs7 units on a scaleStandard Deviation 4.06
Superficial Cervical Plexus BlockNumeric Response Scale Pain Scores at Incision Site at Rest and During CoughingAt rest 48 hrs3.4 units on a scaleStandard Deviation 4.67
UnknownNumeric Response Scale Pain Scores at Incision Site at Rest and During CoughingAt rest 6 hrs units on a scale
UnknownNumeric Response Scale Pain Scores at Incision Site at Rest and During CoughingMovement or cough 6 hrs units on a scale
UnknownNumeric Response Scale Pain Scores at Incision Site at Rest and During CoughingAt rest 12 hrs units on a scale
UnknownNumeric Response Scale Pain Scores at Incision Site at Rest and During CoughingMovement or cough 12 hrs units on a scale
UnknownNumeric Response Scale Pain Scores at Incision Site at Rest and During CoughingAt rest 18 hrs units on a scale
UnknownNumeric Response Scale Pain Scores at Incision Site at Rest and During CoughingMovement or cough 18 hrs units on a scale
Secondary

Post-operative Opioid Consumption Expressed in Morphine Equivalents

Time frame: 24 hours after the surgery

ArmMeasureValue (MEAN)Dispersion
ControlsPost-operative Opioid Consumption Expressed in Morphine Equivalents30.0 mgStandard Deviation 39.16
Superficial Cervical Plexus BlockPost-operative Opioid Consumption Expressed in Morphine Equivalents17.2 mgStandard Deviation 17.5

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026